drugset / Trial / NCT07208799

Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures

NCT07208799

Phase 2 Recruiting 72 enrolled Nishtar Medical University
RandomizedParallel-groupTriple-blindPrevention

Summary

The rationale of the current research is to address the limitation of existing knowledge as it is not clear which of the two drugs (Dexamethasone or Methylprednisolone) is more effective in reduction of postoperative sequelae in patient with mandibular parasymphysis fracture. This study fills the gap by providing sound evidence on the preferred steroid option to help clinicians have more data to make decisions and improve patients' health. The result of this research will then be added to the evidence-based protocols for the treatment of parasymphysis fractures.

Timeline

Start
2026-01-03
Primary completion
2026-11-30
Completion
2026-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 8 mg Other
Comparator Methylprednisolone Other / unclassified 40 mg Other